These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 546335)

  • 21. Enhanced analgesic activity of liposomised Met-enkephalin analogue.
    Khan MF
    Indian J Biochem Biophys; 1981 Dec; 18(6):440-1. PubMed ID: 7333631
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of enkephalins versus opiates on locomotor activity of the horse.
    Nugent TE; Combie JD; Weld JM; Burns P; Tobin T
    Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):405-19. PubMed ID: 7079572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the respiratory activity of (D-Ala2)methionine-enkephalinamide.
    Zobrist RH; Allerton HW; Isom GE
    Eur J Pharmacol; 1981 Mar; 70(2):121-8. PubMed ID: 6790294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noradrenergic terminal excitability: effects of opioids.
    Nakamura S; Tepper JM; Young SJ; Ling N; Groves PM
    Neurosci Lett; 1982 May; 30(1):57-62. PubMed ID: 6124916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphine-induced hyperthermia: lack of cross-tolerance with enkephalin analogs.
    Clark WG; Bernardini GL
    Brain Res; 1982 Jan; 231(1):231-4. PubMed ID: 6275948
    [No Abstract]   [Full Text] [Related]  

  • 26. Analgesic activity of double endorphins in vivo.
    Dorociak A; Misterek K; Rewerski W; Ciupak S
    Acta Physiol Pol; 1984; 35(4):310-6. PubMed ID: 6545925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions.
    Katoh A; Nabeshima T; Kameyama T
    J Pharmacol Exp Ther; 1990 May; 253(2):600-7. PubMed ID: 1971017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo potentiation of [D-Ala2]Met-enkephalin amide central effects after administration of an enkephalinase inhibitor.
    Algeri S; Altstein M; de Simone GM; Guardabasso V
    Eur J Pharmacol; 1981 Sep; 74(2-3):261-2. PubMed ID: 7035191
    [No Abstract]   [Full Text] [Related]  

  • 29. Electroencephalographic and behavioral effects of D-ala2-methionine-enkephalinamide and morphine in the rat.
    Tortella FC; Moreton JE; Khazan N
    J Pharmacol Exp Ther; 1978 Sep; 206(3):636-43. PubMed ID: 702326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Difference in the development of tolerance to morphine and D-ALA2-methionine-enkephalin in C57 BL/6J and DBA/2J mice.
    Frigeni V; Bruno F; Carenzi A; Racagni G
    Life Sci; 1981 Feb; 28(7):729-36. PubMed ID: 7231052
    [No Abstract]   [Full Text] [Related]  

  • 31. Central cardiovascular effects of narcotic analgesics and enkephalins in rats.
    Bellet M; Elghozi JL; Meyer P; Pernollet MG; Schmitt H
    Br J Pharmacol; 1980; 71(2):365-9. PubMed ID: 6110456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oxymorphindole on morphine induced-antinociception in mice and rats.
    Jiang Q; Rice KC; deCosta B; Porreca F
    NIDA Res Monogr; 1990; 105():384-5. PubMed ID: 1652080
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of thiorphan on the antinociceptive actions of intrathecal [D-Ala2,Met5] enkephalin.
    Yaksh TL; Harty GJ
    Eur J Pharmacol; 1982 Apr; 79(3-4):293-300. PubMed ID: 7047177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic activity of the naturally occurring heptapeptide [Met]enkephalin-Arg6-Phe7.
    Inturrisi CE; Umans JG; Wolff D; Stern AS; Lewis RV; Stein S; Udenfriend S
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5512-4. PubMed ID: 6933569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of superfusion of morphine and enkephalins on the activity of single units in the spinal trigeminal nucleus and cuneate nucleus of cat.
    Wong CL; Chan YS; Cheung YM; Hwang JC; Poon PW; Wong TM
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):351-5. PubMed ID: 3736280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A quantitative analysis of the shaking behavior induced in rats by beta-endorphin and [D-Ala2, Met5]enkephalinamide.
    Cowan A; Tortella FC
    Life Sci; 1982 Jan; 30(2):171-6. PubMed ID: 6275233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine and methionine-enkephalin: different effects on spontaneous and evoked neuronal firing in the mesencephalic reticular formation of the rat.
    Hosford DA; Haigler HJ
    J Pharmacol Exp Ther; 1980 May; 213(2):355-63. PubMed ID: 7365695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine and [D-Met2,Pro5]enkephalinamide do not show specific neuroleptic activity.
    Sineger E; Horváth K; Miglécz E; Tarnawa I; Andrási F; Székely JI
    Eur J Pharmacol; 1982 Jun; 80(4):359-68. PubMed ID: 6125401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of (D-Ala2)-Met-enkephalin on the contraction of nictitating membrane in cats.
    Yen MH; Ku PY; Lee HK
    Eur J Pharmacol; 1980 May; 63(2-3):213-6. PubMed ID: 7379855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.